In our paper published by the Seminars in Nephrology journal series of Jan 2024, we extensively review HIV\/TB in kidney disease. We bring together the latest information about diagnosing ad managing this devastating triad.<\/p>\n\n\n\n
Human immunodeficiency virus (HIV) and tuberculosis (TB) are the leading infectious causes of death globally. HIV\/TB have devastating effects on the kidneys, leading to accelerated decline of kidney function as well as mortality. We discuss the\u00a0epidemiology\u00a0of HIV\/TB coinfection and the kidney and the key mechanisms of kidney disease including\u00a0genetic susceptibility. The clinical presentation and pathology, as well as the challenges of diagnosing\u00a0CKD\u00a0in these patients, also are discussed…<\/p>\n\n\n\n
\nWe clearly outline the full spectrum managing these challenging cases across the full spectrum of chronic kidney disease from stage 1 through to end stage kidney disease (kidney failure)..<\/p>\n<\/blockquote>\n\n\n\n
Human immunodeficiency virus (HIV) and tuberculosis (TB) remain two of the world’s leading infectious health challenges, particularly in low- and middle-income regions. While both are heavily recognized for their impact on the immune system and lungs, their combined effect on kidney health is often overlooked\u2014with severe consequences.<\/p>\n\n\n\n
When HIV and TB co-occur, they create a high-risk scenario for kidney damage, accelerating organ decline and raising mortality rates if left unmanaged.<\/p>\n\n\n\n
How HIV and TB Affect the Kidneys<\/h2>\n\n\n\n
The combination of HIV and TB damages the kidneys through several distinct pathways:<\/p>\n\n\n\n
\n
- Direct Infection & Inflammation:<\/strong> HIV can directly infect kidney cells, causing HIV-associated nephropathy (HIVAN). Simultaneously, TB causes systemic inflammation and granulomatous infection that further impairs renal structures.<\/li>\n\n\n\n
- Genetic Vulnerability:<\/strong> Certain genetic factors\u2014such as APOL1<\/em> gene variants common in individuals of African descent\u2014substantially increase the risk of rapid kidney decline when triggered by viral infection.<\/li>\n\n\n\n
- Medication Side Effects & Interactions:<\/strong> Treatment for both diseases requires complex drug regimens. Certain antiretrovirals and anti-TB medications carry risk of kidney toxicity (nephrotoxicity<\/em>), and managing drug-drug interactions without stressing the kidneys requires careful clinical balance.<\/li>\n<\/ul>\n\n\n\n
Diagnosis and Treatment Challenges<\/h3>\n\n\n\n
Managing kidney disease in patients with HIV\/TB coinfection presents unique clinical obstacles:<\/p>\n\n\n\n
\n
- Hidden Progression:<\/strong> Early-stage chronic kidney disease (CKD) rarely causes obvious symptoms. Without routine screening, damage is often discovered late.<\/li>\n\n\n\n
- Dose Adjustments:<\/strong> As kidney function drops, medications must be precisely adjusted to avoid toxic buildup while maintaining effective treatment against both infections.<\/li>\n\n\n\n
- Advanced Care Access:<\/strong> For patients whose kidneys fail, transitioning to long-term dialysis or kidney transplantation requires complex coordination and resources that are often limited in high-burden settings.<\/li>\n<\/ol>\n\n\n\n
Key Steps for Protecting Kidney Health<\/h3>\n\n\n\n
Protecting kidney function in co-infected individuals requires proactive clinical management:<\/p>\n\n\n\n
\n
- Routine Monitoring:<\/strong> Regular blood tests (e.g., serum creatinine, eGFR) and urine tests (proteinuria screening) to catch decline early.<\/li>\n\n\n\n
- Medication Audits:<\/strong> Choosing regimens that minimize kidney toxicity and adjusting dosages as renal clearance changes.<\/li>\n\n\n\n
- Early Antiretroviral & TB Therapy:<\/strong> Prompt, well-managed treatment reduces direct viral and bacterial injury to kidney tissues.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"
In our paper published by the […]<\/p>\n","protected":false},"author":1,"featured_media":9728,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"give_campaign_id":0,"footnotes":""},"categories":[1],"tags":[2,3,4],"class_list":["post-99","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-development","tag-empowerment","tag-social-impact"],"_links":{"self":[{"href":"https:\/\/ugandakidneyfoundation.ug\/index.php?rest_route=\/wp\/v2\/posts\/99","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ugandakidneyfoundation.ug\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ugandakidneyfoundation.ug\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ugandakidneyfoundation.ug\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ugandakidneyfoundation.ug\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=99"}],"version-history":[{"count":1,"href":"https:\/\/ugandakidneyfoundation.ug\/index.php?rest_route=\/wp\/v2\/posts\/99\/revisions"}],"predecessor-version":[{"id":9729,"href":"https:\/\/ugandakidneyfoundation.ug\/index.php?rest_route=\/wp\/v2\/posts\/99\/revisions\/9729"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ugandakidneyfoundation.ug\/index.php?rest_route=\/wp\/v2\/media\/9728"}],"wp:attachment":[{"href":"https:\/\/ugandakidneyfoundation.ug\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=99"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ugandakidneyfoundation.ug\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=99"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ugandakidneyfoundation.ug\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=99"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}